Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DSM265 or OZ439 in induced P. falciparum or P. vivax malaria
NCT02573857Phase 2Terminated
- Sponsor
- Medicines for Malaria Venture
- Start
- Oct 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of DSM265 and artefenomel in malaria, sponsored by Medicines for Malaria Venture. Started Oct 2015; status: terminated.
02
Drugs
DSM265artefenomel
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02573857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02573857.